Verastem Oncology approaches business development through establishing value-creating collaborations. By working together with leading global pharmaceutical companies, we can broaden our pipeline and help advance our efforts to bring new therapies to patients in need.

 

  PRODUCT LICENSING PARTNERSHIP
Chugai

Chugai Logo

CH5126766 Global Licensing Agreement to Develop and Commercialize RAF/MEK Inhibitor (January 2020)

View Press Release

Sanofi

Sanofi Logo

duvelisib Development and Commercialization of Duvelisib in Russia and CIS, Turkey, the Middle East and Africa  (July 2019)

View Press Release

 

CSPC Pharmaceutical Group Limited

CPCS logo

duvelisib Development and Commercialization of Duvelisib in China (September 2018)

View Press Release

 

Yakult Honsha Co., Ltd.

Yakult Logo

duvelisib Development and Commercialization of Duvelisib in Japan (June 2018)

View Press Release